UBS analyst Atul Maheswari lowered the firm’s price target on Purple Innovation to $2.75 from $6.00 and keeps a Neutral rating on the shares. Purple’s Q4 results were in line with its pre-release, but near-term trends coupled with a 2H-weighted guidance is likely to act as a severe overhang on the stock, the analyst tells investors in a research note.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on PRPL:
- Purple Innovation price target lowered to $3 from $3.60 at BofA
- Purple Innovation delays 10-K filing
- Purple Innovation: Coliseum rejects committee’s recent settlement proposal
- Purple Innovation Reports Fourth Quarter and Full Year 2022 Results
- Purple Innovation sees Q1 revenue $105M, consensus $137.13M